Loading company…
Yavne-based Metabomed is a biotech company developing small molecule drugs against novel cancer metabolism targets.
Established in 2013 and based in Yavne, Israel, Metabomed is a biotechnology company that discovers and develops potential small molecule drugs aimed at novel targets in cancer metabolism. It is recorded at the Series B stage in the pharmaceuticals sector.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in